Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently ...

The board of Vor Bio is exploring a potential sale, winding down operations and cutting the vast majority of its workforce.

The cell engineering company, co-founded by oncologist and writer Siddhartha Mukherjee, does not see a path forward for its ...

At the risk of stating the obvious, when evaluating a new EDC, step one is ensuring the EDC is in fact better. EDC technology ...

As the cell and gene therapy (CGT) field continues to mature, many companies face a growing tension between scientific innovation and the realities of clinical development. Unsustainable costs, ...

Combining clinical expertise with advanced engineering, Indian researchers have identified precise anatomical points for ligament reconstruction, marking a major leap forward in the treatment of ...

Hayley Jankowski has been interested in biomedical research since her freshman year of high school. Now, the Rowan University ...

US President Donald Trump’s ongoing efforts to reduce federal spending across government agencies have halted the development ...

A new study finds cold plunges don’t help women recover from workouts, challenging the science behind a trend dominating ...

View Heidelberg Engineering's latest innovations in ophthalmic imaging for research, clinical practice, and ophthalmic surgery at the ARVO 2025 Annual Meeting May 4-8 in Salt Lake City, Utah. Heidelbe ...

The solution provides 99% discovery and visibility of all users, workloads, and devices across IT, IoT, OT, and IoMT ...

Genocury Biotech announces positive results from noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large B-cell lymphoma: Shenzhen, China Friday, May 2, 2025, 15:00 ...